Skip to main content

Table 4 Hazard ratios for survival in diabetic patients with lung cancer based on their use of metformin and/or a TZD, corrected for stage at presentation and age

From: The effect of metformin and thiazolidinedione use on lung cancer in diabetics

  HR (95% CI) P-value
Metformin and/or TZD vs. neither 1.22 (0.96, 1.55) 0.30
Metformin alone vs. neither 1.47 (1.12, 1.92) 0.005
TZD alone vs. neither 1.04 (0.65, 1.66) 0.87